![](/img/cover-not-exists.png)
The effect of PD-L1 categories-directed pembrolizumab plus chemotherapy for newly diagnosed metastatic non-small-cell lung cancer: a cost-effectiveness analysis
Wu, Bin, Lu, ShunVolume:
9
Journal:
Translational Lung Cancer Research
DOI:
10.21037/tlcr-19-605
Date:
October, 2020
File:
PDF, 2.22 MB
2020